Company Dong Sung Bio Pharm.Co.,Ltd.

Company Dong Sung Bio Pharm.Co.,Ltd.

A002210

KR7002210003

Pharmaceuticals

Equities

A002210

KR7002210003

Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Holdings

Company contact information

Sector

Sales per Business

Sales per region

Sector Generic Pharmaceuticals

End-of-day quote Korea S.E. Other stock markets 23:00:00 06/06/2024 BST			5-day change	1st Jan Change
5,040 ^KRW	0.00%		+0.20%	-12.50%

2023	Dong Sung Bio Pharm.Co.,Ltd. announced that it has received KRW 14 billion in funding	CI
2023	Dong Sung Bio Pharm.Co.,Ltd. announced that it expects to receive KRW 14 billion in funding	CI

Dongsung Pharmaceutical Co., Ltd. is a Korea-based company engaged in the manufacture of pharmaceuticals. The Companyâs products include anti-rheumatic, anti-inflammatory analgesics, anti-inflammatory enzymes, drugs for cardiovascular system, gastrointestinal drugs, antispasmodic agents, respiratory agents, anti-histamine, dermatologicals, antibiotics, antidiarrheals, antifungals, oral hypoglycemic agents, hormones, hypnotics and others. It also produces hair dyes and cosmetics. The Company distributes its products within domestic market and to overseas markets.

Number of employees: 290

KRW in Million	2022	Weight	2023	Weight	Delta
Medicine and Hair Dyes 94.9 %	86,729	92.9 %	84,114	94.9 %	-3.01%
Cosmetics 5.1 %	6,599	7.1 %	4,480	5.1 %	-32.12%

KRW in Million	2022	Weight	2023	Weight	Delta
South Korea 81.6 %	86,040	92.2 %	72,321	81.6 %	-15.95%
Overseas 18.4 %	7,288	7.8 %	16,273	18.4 %	+123.28%

Managers	Title	Age	Since
Yang-Gu Lee CEO	Chief Executive Officer	62	-
Chan-Tae Ko AUD	Comptroller/Controller/Auditor	65	-
Bong-Rim Cho PRN	Corporate Officer/Principal	62	-
Sang-Yi Nam PRN	Corporate Officer/Principal	64	-
In-Gyu Kim SAM	Sales & Marketing	69	-

Members of the board	Title	Age	Since
Yang-Gu Lee CEO	Chief Executive Officer	62	-
Young-Ryul Lee BRD	Director/Board Member	66	28/03/19
Won-Gyoon Na BRD	Director/Board Member	38	27/03/22

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	26,100,970	17,319,767 ( 66.36 %)	3,234,982 ( 12.39 %)	66.36 %

Name	Equities	%	Valuation
Yang-Gu Lee 17.05 %	4,451,261	17.05 %	17 M ₩
DONG SUNG BIO PHARM.CO.,LTD. 12.39 %	3,234,982	12.39 %	12 M ₩
Kyeong-hee Lee 1.553 %	405,310	1.553 %	2 M ₩
Yong-hoon Lee 1.260 %	328,899	1.260 %	1 M ₩
Won-Gyoon Na 1.152 %	300,667	1.152 %	1 M ₩
Ju-hyun Kim 0.1237 %	32,297	0.1237 %	121 280 ₩
Yong-joon Lee 0.1095 %	28,574	0.1095 %	107 300 ₩
DFA Australia Ltd. 0.003743 %	977	0.003743 %	3 669 ₩

Name	Equities	%	Valuation
DONG SUNG BIO PHARM.CO.,LTD. 12.39%	3,234,982	12.39%	11,752,528 $

Dongsung Pharmaceutical Co., Ltd.

683 Dobong-ro Dobong-gu

01340, Seoul

http://www.dongsung-pharm.co.kr

address Dong Sung Bio Pharm.Co.,Ltd.(A002210)

	1st Jan change	Capi.
DONG SUNG BIO PHARM.CO.,LTD.	-12.50%	83.63M
SUN PHARMACEUTICAL INDUSTRIES LTD.	+20.14%	43.3B
OTSUKA HOLDINGS CO., LTD.	+23.67%	22.22B
SANDOZ GROUP AG	+15.67%	15.43B
CIPLA LIMITED	+23.10%	14.48B
ZYDUS LIFESCIENCES LIMITED	+57.58%	12.72B
THE MEDICINES COMPANY	-0.05%	6.79B
ONO PHARMACEUTICAL CO., LTD.	-10.69%	6.71B
STADA ARZNEIMITTEL	-8.87%	5.73B
ASPEN PHARMACARE HOLDINGS LIMITED	+14.68%	5.5B

Generic Pharmaceuticals

Healthcare

Pharmaceuticals & Medical Research

Pharmaceuticals

Pharmaceuticals

Generic Pharmaceuticals